Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "Levodopa phobia": a new iatrogenic cause of disability in Parkinson disease.

× No keyword cloud information.

16 in total

1. Risk factors and safe dosage of levodopa for wearing-off phenomenon in Chinese patients with Parkinson's disease.

Authors: Huimin Chen; Jinping Fang; Fangfei Li; Liyan Gao; Tao Feng
Journal: Neurol Sci Date: 2015-01-24 Impact factor: 3.307

2. Geographic Variation in Prescription Patterns of Parkinson's Disease Medications.

Authors: Michiko K Bruno; Gina Watanabe; Kyle Ishikawa; John J Chen; Fay Gao; Kazuma Nakagawa; Deborah Taira
Journal: Mov Disord Date: 2021-12-03 Impact factor: 9.698

3. Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.

Authors: Seung-Nam Kim; Ah-Reum Doo; Ji-Yeun Park; Hyunwoo J Choo; Insop Shim; Jongbae J Park; Younbyoung Chae; Bena Lee; Hyejung Lee; Hi-Joon Park
Journal: Brain Res Date: 2013-12-07 Impact factor: 3.252

Review 4. Continuous drug delivery in Parkinson's disease.

Authors: Marina Senek; Dag Nyholm
Journal: CNS Drugs Date: 2014-01 Impact factor: 5.749

Review 5. Levodopa in the treatment of Parkinson's disease: an old drug still going strong.

Authors: Werner Poewe; Angelo Antonini; Jan Cm Zijlmans; Pierre R Burkhard; François Vingerhoets
Journal: Clin Interv Aging Date: 2010-09-07 Impact factor: 4.458

Review 6. How to optimize the treatment of early stage Parkinson's disease.

Authors: Fabrizio Stocchi; Laura Vacca; Fabiana G Radicati
Journal: Transl Neurodegener Date: 2015-02-25 Impact factor: 8.014

Review 7. Prevalence and definition of drooling in Parkinson's disease: a systematic review.

Authors: J G Kalf; B J M de Swart; G F Borm; B R Bloem; M Munneke
Journal: J Neurol Date: 2009-03-14 Impact factor: 4.849

8. Targeting the progression of Parkinson's disease.

Authors: J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal: Curr Neuropharmacol Date: 2009-03 Impact factor: 7.363

Review 9. Pharmacokinetic optimisation in the treatment of Parkinson's disease : an update.

Authors: Dag Nyholm
Journal: Clin Pharmacokinet Date: 2006 Impact factor: 5.577

10. The modern pre-levodopa era of Parkinson's disease: insights into motor complications from sub-Saharan Africa.

Authors: Roberto Cilia; Albert Akpalu; Fred Stephen Sarfo; Momodou Cham; Marianna Amboni; Emanuele Cereda; Margherita Fabbri; Patrick Adjei; John Akassi; Alba Bonetti; Gianni Pezzoli
Journal: Brain Date: 2014-07-17 Impact factor: 13.501